Life, death, and the pursuit of apoptosis.
暂无分享,去创建一个
[1] D. Bredesen,et al. Expression of the Baculovirus p35 Gene Inhibits Mammalian Neural Cell Death , 1993, Journal of neurochemistry.
[2] W. Kaelin,et al. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] R. Kamen,et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.
[4] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.
[5] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[6] K. Kinzler,et al. Definition of a consensus binding site for p53 , 1992, Nature Genetics.
[7] Y. Tsujimoto,et al. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL , 1995, Nature.
[8] H. Horvitz,et al. Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein , 1995, Nature.
[9] V. Stewart,et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. , 1993, Science.
[10] C. Croce,et al. Inactivation of Bcl-2 by phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[11] E. May,et al. Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. , 1995, Oncogene.
[12] D. Albert,et al. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. , 1994, Genes & development.
[13] Y. Lazebnik,et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE , 1994, Nature.
[14] E. White. Function of the adenovirus E1B oncogene in infected and transformed cells , 1994 .
[15] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[16] Scott W. Lowe,et al. p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.
[17] M. Raff,et al. Programmed cell death and Bcl-2 protection in very low oxygen , 1995, Nature.
[18] M. Su,et al. A novel human protease similar to the interleukin‐1 beta converting enzyme induces apoptosis in transfected cells. , 1995, The EMBO journal.
[19] D. Newmeyer,et al. Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria , 1994, Cell.
[20] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[21] E. Alnemri,et al. Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. , 1995, Cancer research.
[22] R. DePinho,et al. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens , 1994, Nature.
[23] S. Lowe,et al. p53-Dependent apoptosis suppresses tumor growth and progression in vivo , 1994, Cell.
[24] W. Lee,et al. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis , 1994, Molecular and cellular biology.
[25] M. S. Williams,et al. Apoptotic cell death induced by intracellular proteolysis. , 1994, Journal of immunology.
[26] Junying Yuan,et al. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 , 1993, Cell.
[27] E. Shaulian,et al. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. , 1995, Genes & development.
[28] A. Levine,et al. p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[29] Terry Farrah,et al. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.
[30] K. O. Elliston,et al. A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.
[31] S. Lowe,et al. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. , 1993, Genes & development.
[32] E. White,et al. Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein , 1990, Molecular and cellular biology.
[33] A. Berns,et al. Requirement for a functional Rb-1 gene in murine development , 1992, Nature.
[34] E. White,et al. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha , 1992, Molecular and cellular biology.
[35] J. Nevins,et al. Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.
[36] J. Martinou,et al. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K , 1995, Nature.
[37] Suzanne Cory,et al. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship , 1991, Cell.
[38] J. M. Boyd,et al. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins , 1994, Cell.
[39] H. Steller,et al. The head involution defective gene of Drosophila melanogaster functions in programmed cell death. , 1995, Genes & development.
[40] T. Komiyama,et al. Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. , 1994, The Journal of biological chemistry.
[41] John Calvin Reed,et al. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. , 1994, The American journal of pathology.
[42] S. Yonehara,et al. The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. , 1991, International immunology.
[43] R. Craig,et al. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. , 1994, Cancer research.
[44] C. Croce,et al. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. , 1985, Science.
[45] D. Rock,et al. An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1 , 1993, Journal of virology.
[46] H. Horvitz,et al. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2 , 1994, Cell.
[47] S. Korsmeyer,et al. bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.
[48] S. Rees,et al. bcl-2 transgene expression can protect neurons against developmental and induced cell death. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[49] R. J. Clem,et al. Prevention of apoptosis by a baculovirus gene during infection of insect cells. , 1991, Science.
[50] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[51] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.
[52] P. Leder,et al. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death , 1995, Cell.
[53] R. Craig,et al. The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2 , 1995, The Journal of cell biology.
[54] A. Levine,et al. Essential role for p53-mediated transcription in E1A-induced apoptosis. , 1995, Genes & development.
[55] A. Kimchi,et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.
[56] S. Komiyama,et al. Molecular cloning of a human cDNA encoding a novel protein, DAD1, whose defect causes apoptotic cell death in hamster BHK21 cells , 1993, Molecular and cellular biology.
[57] S. Korsmeyer,et al. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[58] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[59] E. White,et al. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein , 1995, Molecular and cellular biology.
[60] John Calvin Reed,et al. FAP-1: a protein tyrosine phosphatase that associates with Fas. , 1995, Science.
[61] T. Noda,et al. bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. , 1995, Cancer research.
[62] E. White,et al. Bcl-2 blocks p53-dependent apoptosis , 1994, Molecular and cellular biology.
[63] Muneesh Tewari,et al. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.
[64] D. Hanahan,et al. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis , 1994, Nature.
[65] M. Fishman,et al. Prevention of vertebrate neuronal death by the crmA gene. , 1994, Science.
[66] C J Kemp,et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. , 1994, Cancer research.
[67] Z. Oltvai,et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.
[68] M. Su,et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.
[69] H. Pan,et al. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. , 1994, Genes & development.
[70] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[71] M. Oren,et al. p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. , 1995, Oncogene.
[72] M. Kaufman,et al. High-frequency developmental abnormalities in p53-deficient mice , 1995, Current Biology.
[73] B. Vogelstein. A deadly inheritance , 1990, Nature.
[74] M. Birnbaum,et al. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs , 1994, Journal of virology.
[75] S. Molineaux,et al. Molecular Cloning and Pro-apoptotic Activity of ICErelII and ICErelIII, Members of the ICE/CED-3 Family of Cysteine Proteases (*) , 1995, The Journal of Biological Chemistry.
[76] E. Alnemri,et al. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. , 1994, The Journal of biological chemistry.
[77] N. Copeland,et al. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. , 1994, Genes & development.
[78] J. Martinou,et al. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. , 1992, Science.
[79] S. Korsmeyer,et al. Bcl-2 protein expression during murine development. , 1994, The American journal of pathology.
[80] A. Wyllie,et al. Cell death: the significance of apoptosis. , 1980, International review of cytology.
[81] T. Jacks,et al. Sunburn and p53 in the onset of skin cancer , 1994, Nature.
[82] M. Raff,et al. Programmed cell death and Bcl‐2 protection in the absence of a nucleus. , 1994, The EMBO journal.
[83] E. White,et al. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins , 1991, Journal of virology.
[84] M. Hengartner,et al. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death , 1992, Nature.
[85] T. Chittenden,et al. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. , 1995, The EMBO journal.
[86] N. Neamati,et al. Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei. , 1995, Journal of immunology.
[87] John Calvin Reed,et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. , 1994, Oncogene.
[88] E. Alnemri,et al. Cloning and Expression of Four Novel Isoforms of Human Interleukin-1β Converting Enzyme with Different Apoptotic Activities (*) , 1995, The Journal of Biological Chemistry.
[89] H. Horvitz,et al. The ins and outs of programmed cell death during C. elegans development. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[90] J. M. Boyd,et al. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. , 1995, Oncogene.
[91] John Calvin Reed,et al. Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity , 1995, Cell.
[92] B. Stillman,et al. Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins , 1987, Journal of virology.
[93] Stephen J. Elledge,et al. Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.
[94] E. White,et al. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.
[95] S. Korsmeyer,et al. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair , 1993, Cell.
[96] G. Evan,et al. c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. , 1994, The EMBO journal.
[97] Bert Vogelstein,et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.
[98] J. Nevins,et al. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis , 1995, Journal of virology.
[99] S. Nagata,et al. The Fas death factor , 1995, Science.
[100] L. Wang,et al. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death , 1994, Cell.
[101] K. Schulze-Osthoff,et al. Cell nucleus and DNA fragmentation are not required for apoptosis , 1994, The Journal of cell biology.
[102] J. Camonis,et al. A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.
[103] W. Fiers,et al. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis , 1995, Nature.
[104] John Calvin Reed,et al. R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl- 2 suppressible mechanism , 1995, The Journal of cell biology.
[105] D. Loh,et al. Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[106] A. Shaw,et al. Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. , 1995, Immunity.
[107] M. Israel,et al. Inhibition of apoptosis by the retinoblastoma gene product. , 1995, The EMBO journal.
[108] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.
[109] T. Shenk,et al. Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[110] D. Goeddel,et al. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.
[111] R. J. Clem,et al. Control of programmed cell death by the baculovirus genes p35 and iap , 1994, Molecular and cellular biology.
[112] M. Berger,et al. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. , 1993, Journal of immunology.
[113] E. White,et al. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. , 1996, Genes & development.
[114] S. Korsmeyer,et al. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death , 1995, Cell.
[115] R. J. Clem,et al. Apoptosis reduces both the in vitro replication and the in vivo infectivity of a baculovirus , 1993, Journal of virology.
[116] C. Prives,et al. Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminus , 1995, Cell.
[117] S. Korsmeyer,et al. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes , 1991, Cell.
[118] Y. Lazebnik,et al. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis , 1993, The Journal of cell biology.
[119] John Calvin Reed,et al. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[120] M. Rowe,et al. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[121] G. Prendergast,et al. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest , 1995, Molecular and cellular biology.
[122] E. White. p53, guardian of Rb , 1994, Nature.
[123] A. Davies,et al. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis , 1993, Cell.
[124] Shai Shaham,et al. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.
[125] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[126] J. Mankovich,et al. Crystal structure of the cysteine protease interleukin-1β-converting enzyme: A (p20/p10)2 homodimer , 1994, Cell.
[127] A. Levine,et al. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. , 1994, Genes & development.
[128] F. McKeon. Nuclear lamin proteins: domains required for nuclear targeting, assembly, and cell-cycle-regulated dynamics. , 1991, Current opinion in cell biology.
[129] E. White,et al. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells , 1994, Journal of virology.
[130] H. Hermeking,et al. Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.
[131] J. Pelletier,et al. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. , 1995, Cancer research.
[132] R. Black,et al. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme , 1992, Cell.
[133] A. Strasser,et al. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice , 1994, Nature.
[134] G. Fröschl,et al. Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase , 1994, The Journal of cell biology.
[135] N. Hay,et al. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.
[136] S. Korsmeyer,et al. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[137] M. Kastan,et al. Growth factor modulation of p53-mediated growth arrest versus apoptosis. , 1995, Genes & development.
[138] J. Nevins,et al. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.
[139] R. J. Clem,et al. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif , 1993, Journal of virology.
[140] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[141] E. Wagner,et al. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. , 1995, Genes & development.
[142] al. et,et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice , 1995, Science.
[143] M. Raff,et al. Social controls on cell survival and cell death , 1992, Nature.
[144] D. Marguet,et al. Homology between reaper and the cell death domains of Fas and TNFR1 , 1995, Cell.
[145] S. Nagata,et al. Involvement of an ICE-like protease in Fas-mediated apoptosis , 1995, Nature.
[146] G M Rubin,et al. Expression of baculovirus P35 prevents cell death in Drosophila. , 1994, Development.
[147] M. Karin,et al. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.
[148] H. Horvitz,et al. Genetic control of programmed cell death in the nematode C. elegans , 1986, Cell.
[149] C. Purdie,et al. Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.
[150] D. Green,et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.
[151] J. Cleveland,et al. Contenders in FasL/TNF death signaling , 1995, Cell.
[152] T. McDonnell,et al. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.
[153] G. Evan,et al. Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.
[154] A. Wyllie,et al. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. , 1994, Oncogene.
[155] J. Sklar,et al. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation , 1986, Cell.
[156] H. Steller,et al. Genetic control of programmed cell death in Drosophila. , 1994, Science.
[157] John Calvin Reed,et al. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA , 1993, Nature.
[158] S. Korsmeyer,et al. Bcl-2 maintains B cell memory , 1991, Nature.
[159] J. Bischoff,et al. Bcl-2 associates with the ras-related protein R-rasp23 , 1993, Nature.
[160] J. Pipas,et al. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53 , 1993, Nature.
[161] R. Craig,et al. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[162] I. Weissman,et al. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. , 1992, Science.
[163] Arul M. Chinnaiyan,et al. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.
[164] J. Weissenbach,et al. Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.
[165] J. Roth,et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression , 1995, Molecular and cellular biology.
[166] R. Weinberg,et al. Effects of an Rb mutation in the mouse , 1992, Nature.
[167] Z. Oltvai,et al. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax , 1994, Nature.
[168] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[169] R. Warnke,et al. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. , 1993, The American journal of pathology.
[170] Y. Lazebnik,et al. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[171] A. Bradley,et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis , 1992, Nature.
[172] Stephen H. Friend,et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product , 1988, Nature.
[173] J. Mankovich,et al. Identification and Characterization of ICH-2, a Novel Member of the Interleukin-1β-converting Enzyme Family of Cysteine Proteases (*) , 1995, The Journal of Biological Chemistry.
[174] Patrick R. Griffin,et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.